Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaMOTS-c

MOTS-c

Mitochondrial-derived peptide

Not ARTG-approved

What it is

A mitochondrial-derived peptide commonly discussed in longevity and metabolic contexts.

What the evidence shows

An interesting research target in metabolism and ageing, but the human evidence is early. Longevity and performance claims are not supported by approved-medicine data.

Safety & reported risks

Unapproved injectable supply carries the usual purity, sterility and oversight concerns.

Status in Australia

Not ARTG-approved. Online supply is not a lawful pathway for human use.

How it’s lawfully accessed

No lawful consumer supply. Not registered for human use.

Related peptides

EpitalonPineal tetrapeptideNot ARTG-approvedSS-31 (Elamipretide)Mitochondrial-targeting peptideInvestigational

Sources & further reading

This entry is general information about MOTS-c, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.